News
Bozeman based LigoCyte Pharmaceuticals http://www.ligocyte.com/ Initiates First Clinical Trial For Bivalent Intramuscular Norovirus Vaccine
September 17, 2010 /
LigoCyte Pharmaceuticals, Inc., a private, clinical-stage biopharmaceuticals company focused on the development of innovative vaccine products, announced that it has initiated the first clinical trial for its bivalent intramuscular (IM) norovirus vaccine candidate, marking the fourth human clinical trial in the Company’s norovirus virus-like particle (VLP) vaccine program.
Full Story: http://www.medicalnewstoday.com/articles/201497.php
MATR Supporters (view all)
Posted in: Biotech
Sorry, we couldn't find any posts. Please try a different search.